A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray.

[1]  G. Settipane,et al.  Double-strength beclomethasone dipropionate (84 μg/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis , 1996 .

[2]  W. Busse,et al.  Asthma and Rhinitis , 1995 .

[3]  R. Zuwallack,et al.  Common measures of asthma severity lack association for describing its clinical course. , 1994, The Journal of allergy and clinical immunology.

[4]  J. Bousquet,et al.  Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray , 1993 .

[5]  R. Zuwallack,et al.  An evaluation of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone. , 1992, Chest.

[6]  R. Mabry.  Topical Pharmacotherapy for Allergic Rhinitis: New Agents , 1992, Southern medical journal.

[7]  J. Bousquet,et al.  Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics. , 1991, The Journal of allergy and clinical immunology.

[8]  P. Venge,et al.  Eosinophils and eosinophil cationic protein in nasal lavages in allergen‐induced hyperresponsiveness: effects of topical glucocorticosteroid treatment , 1989, Allergy.

[9]  E. Duke,et al.  A clinical investigation of the efficacy and safety of mometasone furoate ointment 0.1 percent vs. betamethasone valerate ointment 0.1 percent in the treatment of psoriasis , 1988 .

[10]  S. Siegel.  Topical intranasal corticosteroid therapy in rhinitis. , 1988, The Journal of allergy and clinical immunology.

[11]  R. Naclerio,et al.  Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. , 1988, The Journal of allergy and clinical immunology.

[12]  J. Nuutinen,et al.  One-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis. A preliminary report. , 1987, Rhinology.

[13]  W. Schofield.  Overview and update. , 1987 .

[14]  R. Davies,et al.  Effect of the pollen season on nasal mast cells. , 1987, British medical journal.

[15]  J. Bienenstock,et al.  Effect of beclomethasone dipropionate on nasal metachromatic cell sub‐populations , 1986, Clinical allergy.

[16]  M. Sorri,et al.  Two-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis. , 1983, Rhinology.

[17]  Mali Jw,et al.  [The treatment of psoriasis]. , 1975, Nederlands tijdschrift voor geneeskunde.

[18]  J. T. Connell.  Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane. , 1967, The Journal of allergy.

[19]  E. Juniper,et al.  International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. , 1994, Allergy.

[20]  R. Naclerio.  Drug thearapy : allergic rhinitis , 1991 .

[21]  P. Borum,et al.  Nasal reactivity in rhinitis. , 1983, European journal of respiratory diseases. Supplement.

[22]  R. Brattsand,et al.  Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. , 1982, European journal of respiratory diseases. Supplement.

[23]  K. Austen,et al.  Asthma, physiology, immunopharmacology, and treatment : second international symposium , 1977 .

[24]  K. Austen,et al.  Asthma: physiology, immunopharmacology, and treatment , 1973 .

[25]  J. T. Connell.  Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. , 1969, The Journal of allergy.